Last Updated: Tuesday, August 28, 2012, 19:48
Wockhardt on Tuesday said that it has received US FDA approval for marketing a generic version of extended—release tablets containing Ropinirole hydrochloride.
Last Updated: Thursday, August 16, 2012, 19:45
Wockhardt has received final approval from the United States Food & Drug Administration for marketing tablets of Clopidogrel bisulfate.
Last Updated: Monday, April 25, 2011, 00:00
Wockhardt will be launching the product in the US market on May 28, 2011.